Protalix BioTherapeutics (PLX) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.68 +1.13%
EPS Growth %: -133.3%
Financial Fact:
RESEARCH AND DEVELOPMENT EXPENSES: -6.35M
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: -133.3%
Financial Fact:
RESEARCH AND DEVELOPMENT EXPENSES: -6.35M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported Q2 EPS of ($0.03). Revenue for the quarter came in at $13.47 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Signet shares jump on Q2 profit beat, raised annual guidance
- DA Davidson Reiterates Buy Rating on Braze Inc (BRZE), Says Pullback Presents Attractive Entry Point
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
